Beck Bode LLC Buys 3,886 Shares of Tenet Healthcare Co. (NYSE:THC)

Beck Bode LLC raised its stake in Tenet Healthcare Co. (NYSE:THC - Free Report) by 11.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,803 shares of the company's stock after buying an additional 3,886 shares during the period. Beck Bode LLC's holdings in Tenet Healthcare were worth $4,898,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. GeoWealth Management LLC boosted its position in Tenet Healthcare by 39.8% during the fourth quarter. GeoWealth Management LLC now owns 295 shares of the company's stock valued at $37,000 after buying an additional 84 shares during the period. WR Wealth Planners LLC boosted its holdings in Tenet Healthcare by 2,836.4% during the 4th quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock valued at $41,000 after acquiring an additional 312 shares during the period. Smartleaf Asset Management LLC boosted its stake in shares of Tenet Healthcare by 30.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company's stock valued at $59,000 after purchasing an additional 110 shares during the period. Kestra Investment Management LLC purchased a new position in shares of Tenet Healthcare in the fourth quarter worth $60,000. Finally, Wilmington Savings Fund Society FSB boosted its position in Tenet Healthcare by 1,352.8% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company's stock valued at $66,000 after buying an additional 487 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on THC shares. The Goldman Sachs Group upped their price objective on shares of Tenet Healthcare from $134.00 to $154.00 and gave the company a "neutral" rating in a research note on Monday. Morgan Stanley upped their price target on Tenet Healthcare from $165.00 to $175.00 and gave the company an "overweight" rating in a research report on Monday. Royal Bank of Canada boosted their target price on Tenet Healthcare from $183.00 to $189.00 and gave the company an "outperform" rating in a research note on Wednesday, April 30th. UBS Group raised their price target on Tenet Healthcare from $217.00 to $230.00 and gave the stock a "buy" rating in a research note on Wednesday, April 30th. Finally, KeyCorp decreased their price objective on shares of Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, Tenet Healthcare currently has an average rating of "Moderate Buy" and an average target price of $173.69.

Insiders Place Their Bets

In related news, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares of the company's stock, valued at approximately $3,434,022.54. This represents a 25.81 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.81% of the company's stock.

Tenet Healthcare Stock Up 0.4 %

Shares of Tenet Healthcare stock traded up $0.68 during midday trading on Wednesday, hitting $152.16. The company had a trading volume of 1,244,286 shares, compared to its average volume of 1,551,921. Tenet Healthcare Co. has a 52-week low of $109.82 and a 52-week high of $171.20. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. The company has a 50 day moving average of $128.37 and a 200 day moving average of $136.22. The stock has a market capitalization of $14.13 billion, a P/E ratio of 4.72, a P/E/G ratio of 1.02 and a beta of 1.63.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $1.25. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The company had revenue of $5.22 billion during the quarter, compared to analyst estimates of $5.15 billion. During the same period in the previous year, the business posted $3.22 earnings per share. The firm's quarterly revenue was down 2.5% compared to the same quarter last year. On average, equities analysts predict that Tenet Healthcare Co. will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.